Exogenous NO donor 3,3-bis-(nitroxymethyl)oxetane (NMO) was synthesized at the Institute for Problems of Chemical Physics (Russian Academy of Sciences). This compound was shown to inhibit Ca2+-ATPase isolated from normal muscular cells and tumor cells. Both hydrolytic and transport functions of the enzyme were inhibited under these conditions. These changes were probably related to changes in membrane structure caused by NO donor. Our results suggest that changes in intracellular Ca2+ concentration can modulate the formation of tumor drug resistance.
Similar content being viewed by others
References
S. Ya. Proskuryakov, A. G. Konoplyannikov, A. I. Ivannikov, et al., Vopr. Onkol., 47, No. 3, 257–269 (2001).
I. S. Severina, Biokhimiya, 63, No. 7, 939–947 (1998).
I. P. Seraya and Ya. R. Nartsissov, Uspekhi Sovrem. Biol., 122, No. 3, 249–258 (2002).
Y. M. Kim and S. G. Paik, Biochem. Biophys. Res. Commun., 326, No. 2, 410–416 (2005).
N. P. Konovalova, S. A. Goncharova, L. M. Volkova, et al., Nitric Oxide, 8, No. 1, 59–64 (2003).
M. Lahiri and J. H. Martin, Oncol. Rep., 12, No. 5, 1007–1011 (2004).
N. E. Matthews, M. A. Adams, L. R. Maxwell, et al., J. Natl. Cancer Inst., 93, No. 24, 1879–1885 (2001).
N. Mestdagh, B. Vandewalle, L. Hornez, and J. P. Henichart, Biochem. Pharmacol., 48, No. 4, 709–716 (1994).
S. Padar, C. van Breemen, D. W. Thomas, et al., Br. J. Pharmacol., 142, No. 2, 305–316 (2004).
C. Riganti, E. Miraglia, D. Viarisio, et al., Cancer Res., 65, No. 2, 516–525 (2005).
C. Riganti, S. Orecchia, G. Pescarmona, et al., Int. J. Cancer, 119, No. 1, 17–27 (2006).
I. N. Sergeev, J. Steroid Biochem. Mol. Biol., 89–90, Nos. 1–5, 419–425 (2004).
J. Vilpo, T. Koski, and L. Vilpo, Haematologica, 85, No. 8, 806–813 (2000).
Author information
Authors and Affiliations
Additional information
Translated from Byulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 146, No. 8, pp. 165–167, August, 2008
Rights and permissions
About this article
Cite this article
Rajewskaya, T.A., Goncharova, S.A., Konovalova, N.P. et al. Effect of drug resistance modulator, NO donor, on membrane structure and function of membrane-bound Ca2+-activated Mg2+-dependent ATPase. Bull Exp Biol Med 146, 200–202 (2008). https://doi.org/10.1007/s10517-008-0253-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-008-0253-9